NDC 36987-2078

Rhizopus oryzae

Rhizopus Oryzae

Rhizopus oryzae is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Rhizopus Arrhizus Var. Arrhizus.

Product ID36987-2078_3fd958a1-76f3-4d4b-9233-7cf3da1c304b
NDC36987-2078
Product TypeHuman Prescription Drug
Proprietary NameRhizopus oryzae
Generic NameRhizopus Oryzae
Dosage FormInjection, Solution
Route of AdministrationINTRADERMAL; SUBCUTANEOUS
Marketing Start Date1972-08-29
Marketing CategoryBLA / BLA
Application NumberBLA102192
Labeler NameNelco Laboratories, Inc.
Substance NameRHIZOPUS ARRHIZUS VAR. ARRHIZUS
Active Ingredient Strength0 g/mL
Pharm ClassesNon-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 36987-2078-2

10 mL in 1 VIAL, MULTI-DOSE (36987-2078-2)
Marketing Start Date1972-08-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 36987-2078-1 [36987207801]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-2078-4 [36987207804]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-2078-2 [36987207802]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-2078-3 [36987207803]

Rhizopus oryzae INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
RHIZOPUS ARRHIZUS VAR. ARRHIZUS.05 g/mL

OpenFDA Data

SPL SET ID:4a853ed7-32f7-44bf-bea1-3e90994e7651
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1006300
  • 1012146
  • 852041
  • 968203
  • 1006288
  • 852243
  • 314941
  • 967777
  • 968478
  • 889590
  • 1011974
  • 1011976
  • 1011972
  • 1012035
  • 1010904
  • 1012051
  • 968133
  • 1012171
  • 1006321
  • 967947
  • 967532
  • 905073
  • 966683
  • 968544
  • 852800
  • 883409
  • 968440
  • 968429
  • 967038
  • 967051
  • 1012047
  • 1012041
  • 967985
  • Pharm Class PE
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Increased Histamine Release [PE]
  • PHarm Class EPC
  • Non-Standardized Fungal Allergenic Extract [EPC]
  • NUI Code
  • N0000185001
  • N0000175629
  • N0000171131
  • N0000185372
  • N0000169106
  • N0000184306
  • Pharmacological Class

    • Non-Standardized Fungal Allergenic Extract [EPC]
    • Increased Histamine Release [PE]
    • Cell-mediated Immunity [PE]
    • Increased IgG Production [PE]
    • Fungal Proteins [Chemical/Ingredient]
    • Allergens [Chemical/Ingredient]

    NDC Crossover Matching brand name "Rhizopus oryzae" or generic name "Rhizopus Oryzae"

    NDCBrand NameGeneric Name
    22840-2619Rhizopus oryzaeRhizopus oryzae
    22840-2620Rhizopus oryzaeRhizopus oryzae
    22840-2621Rhizopus oryzaeRhizopus oryzae
    22840-5633Rhizopus oryzaeRhizopus oryzae
    36987-2073Rhizopus oryzaeRhizopus oryzae
    36987-2074Rhizopus oryzaeRhizopus oryzae
    36987-2075Rhizopus oryzaeRhizopus oryzae
    36987-2076Rhizopus oryzaeRhizopus oryzae
    36987-2077Rhizopus oryzaeRhizopus oryzae
    36987-2078Rhizopus oryzaeRhizopus oryzae
    36987-2079Rhizopus oryzaeRhizopus oryzae
    36987-2080Rhizopus oryzaeRhizopus oryzae
    36987-2081Rhizopus oryzaeRhizopus oryzae
    49643-118RhizopusRhizopus oryzae

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.